Olivia Ashman

Views & Analysis

Pfizer’s Dr Olivia Ashman joined me for episode 16 of the pharmaphorum podcast, which focuses on the UK cancer landscape.

News

UK start-up Potential Sciences emerged from stealth today with a sizeable seed funding round and an ambition to transform drug discovery with AI.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.